Cefprozil Oral Suspension Generic Name & Formulations
Cefprozil 125mg/5mL, 250mg/5mL; bubble-gum flavor; contains phenylalanine.
Cefprozil Oral Suspension Indications
Susceptible mild to moderate infections, including pharyngitis/tonsillitis, secondary bacterial infection of acute bronchitis, acute bacterial exacerbation of chronic bronchitis, acute sinusitis, skin and skin structure, otitis media.
Cefprozil Oral Suspension Dosage and Administration
≥13yrs: Pharyngitis/tonsillitis: 500mg every 24hrs. Acute sinusitis: 250mg (mild) or 500mg (moderate to severe) every 12hrs. Bronchitis: 500mg every 12hrs. Skin and skin structure: 250mg every 12hrs or 500mg every 12–24hrs. All: for 10 days. CrCl<30mL/min: 50% of standard dose.
Otitis media: <6 months: not recommended; 6 months to 12yrs: 15mg/kg every 12hrs. Acute sinusitis: <6 months: not recommended; 6months to 12yrs: 7.5mg/kg (mild) or 15mg/kg (moderate to severe) every 12hrs. Pharyngitis/tonsillitis: <2yrs: not recommended; 2–12yrs: 7.5mg/kg every 12hrs. Skin and skin structure: <2yrs: not recommended; 2–12yrs: 20mg/kg every 24hrs. All: for 10 days.
Cefprozil Oral Suspension Contraindications
Cefprozil Oral Suspension Boxed Warnings
Cefprozil Oral Suspension Warnings/Precautions
Penicillin or other allergy. Renal impairment, reduce dose. Monitor renal function. GI disease (esp. colitis). Labor & delivery. Pregnancy (Cat.B). Nursing mothers.
Cefprozil Oral Suspension Pharmacokinetics
Cefprozil Oral Suspension Interactions
Avoid diuretics, other nephrotoxic drugs, including aminoglycosides. Potentiated by probenecid. May cause false (+) Clinitest.
Cefprozil Oral Suspension Adverse Reactions
GI upset, elevated liver enzymes, dizziness.
Cefprozil Oral Suspension Clinical Trials
Cefprozil Oral Suspension Note
Formerly known under the brand name Cefzil.
Cefprozil Oral Suspension Patient Counseling